Lion Point Capital, LP - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Lion Point Capital, LP ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$853,200
+22.1%
27,0000.0%0.38%
+20.3%
Q2 2023$698,490
-70.0%
27,000
-72.2%
0.32%
-67.0%
Q1 2023$2,329,940
+12.7%
97,0000.0%0.96%
+226.2%
Q4 2022$2,068,000
+20.6%
97,000
+21.2%
0.29%
-22.2%
Q3 2022$1,715,00080,0000.38%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,921,118$38,077,0005.86%
FRAZIER MANAGEMENT LLC 3,566,912$70,696,0005.67%
Burrage Capital Management LLC 205,866$4,080,0003.31%
Novo Holdings A/S 2,445,147$48,463,0002.00%
NEA Management Company, LLC 4,187,801$83,002,0001.86%
Sio Capital Management, LLC 437,138$8,664,0001.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$68,357,0001.44%
Rock Springs Capital Management LP 1,502,800$29,785,0000.65%
Sofinnova Investments, Inc. 476,401$9,442,0000.57%
Boxer Capital, LLC 317,000$6,283,0000.21%
View complete list of MIRUM PHARMACEUTICALS INC shareholders